ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Pain Medicine

Top Pain Medicine Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ASHRAF HENRY M.D.

Pain Medicine

5,602

$339K

340
67 are 65+

47%
patients receiving schedule two controlled substances

Avg: 46%

50%
patients receiving schedule three controlled substances

Avg: 19%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $121

PRATIBHA BANSAL MD

Pain Medicine

3,298

$176K

480
71 are 65+

41%
patients receiving schedule two controlled substances

Avg: 46%

37%
patients receiving schedule three controlled substances

Avg: 19%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $121

IAN YANG MD

Pain Medicine

2,780

$242K

166
60 are 65+

28%
patients receiving schedule two controlled substances

Avg: 46%

38%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$87
Average prescription price

Avg: $121

VADIM KUSHNERIK M.D.

Pain Medicine

2,577

$359K

257
105 are 65+

53%
patients receiving schedule two controlled substances

Avg: 46%

15%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 26%

$139
Average prescription price

Avg: $121

GORDON FREEDMAN MD

Pain Medicine

2,498

$820K

238
138 are 65+

77%
patients receiving schedule two controlled substances

Avg: 46%

10%
patients receiving schedule three controlled substances

Avg: 19%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 26%

$328
Average prescription price

Avg: $121

JOEL KREITZER MD

Pain Medicine

2,387

$342K

286
187 are 65+

58%
patients receiving schedule two controlled substances

Avg: 46%

9%
patients receiving schedule three controlled substances

Avg: 19%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 26%

$143
Average prescription price

Avg: $121

ROMATH WAGHMARAE

Pain Medicine

2,304

$483K

217
71 are 65+

49%
patients receiving schedule two controlled substances

Avg: 46%

37%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

49%
prescriptions for brand name drugs

Avg: 26%

$210
Average prescription price

Avg: $121

TOMASZ ANDREJUK M.D.

Pain Medicine

2,274

$251K

208
50 are 65+

59%
patients receiving schedule two controlled substances

Avg: 46%

43%
patients receiving schedule three controlled substances

Avg: 19%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 26%

$110
Average prescription price

Avg: $121

HARVEY FINKELSTEIN MD

Pain Medicine

2,183

$337K

185
81 are 65+

68%
patients receiving schedule two controlled substances

Avg: 46%

12%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$155
Average prescription price

Avg: $121

VINOO THOMAS M.D.

Pain Medicine

2,075

$459K

285
156 are 65+

80%
patients receiving schedule two controlled substances

Avg: 46%

12%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 26%

$221
Average prescription price

Avg: $121

MEHRDAD HEDAYATNIA MD

Pain Medicine

2,058

$264K

398
236 are 65+

66%
patients receiving schedule two controlled substances

Avg: 46%

17%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$128
Average prescription price

Avg: $121

ASHRAF SABAHAT MD

Pain Medicine

1,997

$190K

160
61 are 65+

59%
patients receiving schedule two controlled substances

Avg: 46%

38%
patients receiving schedule three controlled substances

Avg: 19%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$95
Average prescription price

Avg: $121

ANURAG BHATIA MD

Pain Medicine

1,934

$70.9K

399
220 are 65+

46%
patients receiving schedule two controlled substances

Avg: 46%

50%
patients receiving schedule three controlled substances

Avg: 19%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

6%
prescriptions for brand name drugs

Avg: 26%

$37
Average prescription price

Avg: $121

CALVIN CHIANG MD

Pain Medicine

1,763

$178K

237
106 are 65+

38%
patients receiving schedule two controlled substances

Avg: 46%

10%
patients receiving schedule three controlled substances

Avg: 19%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$101
Average prescription price

Avg: $121

ANDREW DAVY MD

Pain Medicine

1,578

$378K

183
54 are 65+

48%
patients receiving schedule two controlled substances

Avg: 46%

23%
patients receiving schedule three controlled substances

Avg: 19%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$240
Average prescription price

Avg: $121

UNA SIBIRCEVA MD

Pain Medicine

1,568

$209K

203
119 are 65+

35%
patients receiving schedule two controlled substances

Avg: 46%

8%
patients receiving schedule three controlled substances

Avg: 19%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$133
Average prescription price

Avg: $121

EDWARD RUBIN M.D.

Pain Medicine

1,466

$291K

192
111 are 65+

66%
patients receiving schedule two controlled substances

Avg: 46%

15%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 26%

$198
Average prescription price

Avg: $121

FARROKH MANEKSHA M.D.

Pain Medicine

1,381

$341K

79
24 are 65+

84%
patients receiving schedule two controlled substances

Avg: 46%

18%
patients receiving schedule three controlled substances

Avg: 19%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 26%

$247
Average prescription price

Avg: $121

MARIVI DE JESUS M.D.

Pain Medicine

1,350

$85.1K

103
42 are 65+

21%
patients receiving schedule two controlled substances

Avg: 46%

24%
patients receiving schedule three controlled substances

Avg: 19%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $121

GRACE FORDE M.D.

Pain Medicine

1,342

$195K

149
81 are 65+

46%
patients receiving schedule two controlled substances

Avg: 46%

13%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 26%

$145
Average prescription price

Avg: $121

ROBERT OLEARY M.D.

Pain Medicine

1,264

$76.2K

117
60 are 65+

50%
patients receiving schedule two controlled substances

Avg: 46%

27%
patients receiving schedule three controlled substances

Avg: 19%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $121

JERRY TRACY

Pain Medicine

1,260

$148K

337
110 are 65+

63%
patients receiving schedule two controlled substances

Avg: 46%

32%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$117
Average prescription price

Avg: $121

MATHEW LEFKOWITZ MD

Pain Medicine

1,253

$103K

320
217 are 65+

30%
patients receiving schedule two controlled substances

Avg: 46%

7%
patients receiving schedule three controlled substances

Avg: 19%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 26%

$83
Average prescription price

Avg: $121

MEHRAN GOLPARIANI MD

Pain Medicine

1,237

$121K

175
97 are 65+

58%
patients receiving schedule two controlled substances

Avg: 46%

31%
patients receiving schedule three controlled substances

Avg: 19%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 26%

$97
Average prescription price

Avg: $121

LEONID REYFMAN MD

Pain Medicine

1,118

$132K

294
196 are 65+

24%
patients receiving schedule two controlled substances

Avg: 46%

15%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 26%

$118
Average prescription price

Avg: $121

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank